7418-66-8Relevant articles and documents
POLY-ADP RIBOSE POLYMERASE (PARP) INHIBITORS
-
, (2018/07/29)
The present invention is related to a pharmaceutical composition comprising a pharmaceutically acceptable carrier or diluent and a compound represented by the following structural formula: The present invention is also related a method of treating a subject with a disease which can be ameliorated by inhibition of poly(ADP-ribose)polymerase (PARP). The definitions of the variables are provided herein.
Ring-Opening Reactions of Triazolo- and Tetrazolo-Pyridopyrimidines or Quinazolines with some Carbon Nucleophiles
Petric, Andrej,Tisler, Miha,Stanovnik, Branko
, p. 1309 - 1320 (2007/10/02)
Syntheses of some new pyridotriazolo- and pyridotetrazolopyrimidines are described.These tricyclic systems and tetrazoloquinazoline react with some carbon nucleophiles, generated from compounds with reactive methylene groups, exclusively at position 2 of